Researcher.Life Logo

SLAS Discovery : Impact Factor & More

eISSN: 2472-5560pISSN: 2472-5552
JournalOpen Access

Key Metrics

CiteScore
5.4
H-Index
28
Impact Factor
< 5
SJR
Q1Biochemistry
SNIP
0.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on SLAS Discovery

SLAS Discovery Journal Specifications

Overview
Publisher ELSEVIER SCIENCE INC
Language English
Frequency Monthly
Article Processing ChargesUSD 1800
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorSociety for Laboratory Automation and Screening
FrequencyMonthly
Publication Start Year2017
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in SLAS Discovery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in SLAS Discovery

Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
Cleaving through complexity: Pan-serotype fluorimetric assays for the dengue virus proteases.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
Response to letter regarding "AI‑based analysis of label‑free live‑cell imaging of T‑cell-mediated tumor killing".
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
FRET prioritization score to choose high-quality hit equity and reduce the impact of interference by quenching and fluorescence.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.
  • 23 Jun 2026
  • SLAS discovery : advancing life sciences R & D
Repurposing drug screen for the identification of helicase inhibitors from viruses of pandemic concern.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
Cleaving through complexity: Pan-serotype fluorimetric assays for the dengue virus proteases.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
Response to letter regarding "AI‑based analysis of label‑free live‑cell imaging of T‑cell-mediated tumor killing".
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
FRET prioritization score to choose high-quality hit equity and reduce the impact of interference by quenching and fluorescence.
  • 1 Aug 2026
  • SLAS discovery : advancing life sciences R & D
A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.
  • 23 Jun 2026
  • SLAS discovery : advancing life sciences R & D

FAQs on SLAS Discovery